Grace Therapeutics, Inc.

Biotechnology • Healthcare • Princeton, NJ, United States • GRCE (NCM)

Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray of betamethasone to improve neurological symptoms of Ataxia-Telangiectasia (A-T) and GTX-101, a topical bioadhesive film-forming polymer for the treatment of pain associated with postherpetic neuralgia (PHN). The company was formerly known as Acasti Pharma Inc. and changed its name to Grace Therapeutics, Inc. in October 2024. Grace Therapeutics, Inc. was incorporated in 2002 and is headquartered in Princeton, New Jersey.

609 322 1602 103 Carnegie Center, Princeton, NJ 08540, United States

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Is Grace Therapeutics Inc. stock supported by strong fundamentals - Sector-Based Investing & Create Passive Income With Smart Stocks - bollywoodhelpline.com

bollywoodhelpline.com • Jan 1

Grace Therapeutics, Inc. (NASDAQ:GRCE) Is Expected To Breakeven In The Near Future - Yahoo Finance

Yahoo Finance • Jun 24

Grace Therapeutics, Inc. (NASDAQ:GRCE): When Will It Breakeven? - simplywall.st

simplywall.st • Jun 10

Grace (NASDAQ: GRCE) secures $4.0M as FDA accepts NDA for GTx-104; PDUFA date set - Stock Titan

Stock Titan • Oct 23

Corcept Therapeutics Stock Sinks On FDA Setback For Relacorilant - Sahm

Sahm • Dec 31

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Grace Therapeutics, Inc. had layoffs?

No layoff events have been recorded for Grace Therapeutics, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Grace Therapeutics, Inc. have?

Grace Therapeutics, Inc. has approximately 6 employees.

What industry is Grace Therapeutics, Inc. in?

Grace Therapeutics, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Grace Therapeutics, Inc. a publicly traded company?

Yes, Grace Therapeutics, Inc. is publicly traded under the ticker symbol GRCE on the NCM. The company has a market capitalization of approximately $0.05 billion.

Where is Grace Therapeutics, Inc. headquartered?

Grace Therapeutics, Inc. is headquartered in Princeton, NJ, United States at 103 Carnegie Center, Princeton, NJ 08540, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.